Loading…

Clinical evaluation of primary endoscopic frontal sinus surgery grade 6 (Draf III) in patients with moderate to severe eosinophilic chronic rhinosinusitis with polyps: a randomized study

Background Endoscopic sinus surgery (ESS) is an effective treatment for chronic rhinosinusitis (CRS) that does not respond to proper conventional treatment. The Draf 2A frontal sinusotomy is the most used procedure for this purpose and Draf III is classically reserved for revision cases. The aim of...

Full description

Saved in:
Bibliographic Details
Published in:The Egyptian journal of otolaryngology 2024-12, Vol.40 (1), p.174-8
Main Authors: Elshamy, Ibrahim Talal, Askar, Mohammed Hamed, Khalifa, Mohammed Adel, Tomoum, Mohammed Osama, Hamad, Mohammed Hesham Ali
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Endoscopic sinus surgery (ESS) is an effective treatment for chronic rhinosinusitis (CRS) that does not respond to proper conventional treatment. The Draf 2A frontal sinusotomy is the most used procedure for this purpose and Draf III is classically reserved for revision cases. The aim of this study was to assess the impact of primary endoscopic frontal sinus surgeries grade 6 (Draf III) on the clinical results of individuals with moderate to severe eosinophilic CRS with Nasal Polyps (CRS w NP). Methods This double-blinded, pilot randomized, prospective, controlled, work included 50 individuals who had moderate to severe eosinophilic CRS w NP. These individuals were separated into two groups. Group A: 25 individuals underwent wide corridor paranasal sinus surgery including endoscopic frontal sinus surgery grade 6 (Draf III). Group B: 25 patients received wide corridor paranasal sinus surgery including endoscopic frontal sinus surgery grade 1–3 (Draf I or IIa). Results Rhinologic symptom score, extra-nasal rhinologic score, psychological dysfunction score, facial/ear symptoms, sleep score, and total of SNOT 22 were significantly lower in follow-up at 1 year than preoperative in group Draf III and group Draf I or IIa ( P value 
ISSN:1012-5574
2090-8539
DOI:10.1186/s43163-024-00720-3